RGEBX
Price
$81.45
Change
+$1.12 (+1.39%)
Updated
Aug 12 closing price
Net Assets
324.88B
TWRCX
Price
$51.35
Change
+$0.63 (+1.24%)
Updated
Aug 12 closing price
Net Assets
15.7B
Interact to see
Advertisement

RGEBX vs TWRCX

Header iconRGEBX vs TWRCX Comparison
Open Charts RGEBX vs TWRCXBanner chart's image
American Funds Growth Fund of Amer R2E
Price$81.45
Change+$1.12 (+1.39%)
VolumeN/A
Net Assets324.88B
American Century Growth C
Price$51.35
Change+$0.63 (+1.24%)
VolumeN/A
Net Assets15.7B
RGEBX vs TWRCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
RGEBX vs. TWRCX commentary
Aug 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RGEBX is a Buy and TWRCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 325B vs. TWRCX (15.7B). RGEBX (0.00) and TWRCX (0.00) have matching dividends . RGEBX was incepted earlier than TWRCX: RGEBX (11 years) vs TWRCX (15 years). TWRCX (1.97) is less costly to investors than RGEBX (1.09). RGEBX is a more actively managed with annual turnover of: 25.00 vs. TWRCX (21.00). RGEBX has a lower initial minimum investment than TWRCX: RGEBX (250) vs TWRCX (2500). RGEBX annual gain was more profitable for investors over the last year : 18.71 vs. TWRCX (12.74). RGEBX return over 5 years is better than : 40.58 vs. TWRCX (32.91).
RGEBXTWRCXRGEBX / TWRCX
Total Expense Ratio1.091.8958%
Annual Report Gross Expense Ratio1.091.9755%
Fund Existence11 years15 years-
Gain YTD14.0127.140196%
Front LoadN/AN/A-
Min. Initial Investment250250010%
Min. Initial Investment IRAN/AN/A-
Net Assets325B15.7B2,070%
Annual Yield % from dividends0.000.00-
Returns for 1 year18.7112.74147%
Returns for 3 years40.7336.79111%
Returns for 5 years40.5832.91123%
Returns for 10 years80.2075.08107%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CTKB4.030.24
+6.33%
Cytek Biosciences
DXC13.260.41
+3.19%
DXC Technology Company
EUDA2.590.07
+2.78%
EUDA Health Holdings Limited
THC170.483.85
+2.31%
Tenet Healthcare Corp
ARTL9.72-0.31
-3.09%
Artelo Biosciences Inc